MACTIVATION Study for Systemic Lupus Erythematosus
Mac-1:GP1b alpha and Immune Activation: Novel Mechanisms of Cardiovascular Events in Systemic Lupus Erythematosus (MACTIVATION-SLE)
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: Yes
- Type: Tissue Banking or Laboratory Collection
- Trial Phase: NA
- Conditions Being Studied: Systemic Lupus Erythematosus
Study Purpose
The purpose of this study is to understand the impact of your immune system on blood platelets, which are cells that circulate in the bloodstream and help form blood clots. Blood clots are important if you are bleeding, but when platelets are incorrectly activated, strokes and heart attacks can occur. This study will use blood samples to determine whether platelets are activated at the same time as SLE disease activity.
Who Can Participate
Participants between 18 years and older who have been diagnosed with systemic lupus erythematosis may be eligible for this study. Participants without an auto immune disorder are also needed for this study. These participants will have one visit which will include a blood test and survey related to their health.
Locations
UH Minoff Health Center at Chagrin Highlands
3909 Orange Place
Orange Village OH, 44122
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: STUDY20210597
- StudyID: 2021-0607
- ClinicalTrials.gov: N/A
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422